[{"data":1,"prerenderedAt":364},["ShallowReactive",2],{"slug-big-pharma-part-3":3},{"post":4,"relatedPosts":202,"relatedBooks":363},{"id":5,"date":6,"date_gmt":7,"guid":8,"modified":10,"modified_gmt":11,"slug":12,"status":13,"type":14,"link":15,"title":16,"content":18,"excerpt":21,"author":23,"featured_media":24,"comment_status":25,"ping_status":25,"sticky":26,"template":27,"format":28,"meta":29,"categories":30,"tags":35,"project_category":56,"contact_email_category":60,"yst_prominent_words":61,"class_list":71,"better_featured_image":105,"acf":137,"yoast_meta":146,"_links":149},36697,"2021-11-04T10:00:00","2021-11-04T09:00:00",{"rendered":9},"https:\u002F\u002Fmedicalfuturist.com\u002F?post_id=36697&_wpnonce=3c32e44344&status=auto-draft&type=post","2021-11-05T00:47:49","2021-11-04T23:47:49","big-pharma-part-3","publish","post","https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-part-3",{"rendered":17},"Digital Health Interests Of Pharma Giants Boehringer Ingelheim, Takeda, Astrazeneca, Amgen And Roche",{"rendered":19,"protected":20},"\n\u003Cp>\u003Cstrong>With their extending reaches, resources and influence, pharmaceutical heavyweights have the potential to shape the digital health landscape to line up with their interests. And to have a better picture of where those interests lie, it is worth taking a look at what moves pharma giants are making in this sphere. With this in mind, we started a series of articles focusing on the digital health efforts of 14 global pharma companies. \u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp>The \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-part-one\u002F\" target=\"_blank\">first article\u003C\u002Fa> explored developments coming from Johnson & Johnson, Pfizer, Bayer and Novartis, while the \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-part-2\u002F\" target=\"_blank\">second article\u003C\u002Fa> investigated those coming from Merck, GlaxoSmithKline, AbbVie, Sanofi and Bristol Myers Squibb. This third article, which will conclude the series, will peek into the digital health trends that pharma giants Boehringer Ingelheim, Takeda, AstraZeneca, Amgen and Roche have taken an interest in.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Boehringer Ingelheim: leaning on the patient side of the equation\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>To boost opportunities for innovators and digital health tech uptake in the UK, pharma giant Boehringer Ingelheim (BI) \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fdigitalhealth.london\u002Fbi-launches-new-guide-to-help-unlock-nhs-for-innovators-and-accelerate-uptake-of-digital-health-tech\" target=\"_blank\">launched a new guide\u003C\u002Fa> in December 2020. It provides entrepreneurs with insights into the NHS, as well as potential pathways to sustainably improve the health system’s services with emerging technologies.\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002F100_why-dont-digital-health-investors-finance-hard-topics-768x432.png\" alt=\"digital health investors\" class=\"wp-image-24505\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002F100_why-dont-digital-health-investors-finance-hard-topics-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002F100_why-dont-digital-health-investors-finance-hard-topics-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002F100_why-dont-digital-health-investors-finance-hard-topics-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002F100_why-dont-digital-health-investors-finance-hard-topics-2048x1152.png 2048w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002F100_why-dont-digital-health-investors-finance-hard-topics.png 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>BI has also made moves to improve the patient side of the digital health equation. Like its counterparts \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-part-one\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">Pfizer\u003C\u002Fa> and \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-part-2\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">Bristol Myers Squibb\u003C\u002Fa>, BI has developed a liking for \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fwhat-are-digital-therapeutics\" target=\"_blank\" rel=\"noreferrer noopener\">digital therapeutics (DTx)\u003C\u002Fa>. In September 2020, the pharma company signed \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fboehringer-ingelheim-click-therapeutics-ink-500m-digital-therapeutics-development\" target=\"_blank\" rel=\"noreferrer noopener\">a $500 million deal with Click Therapeutics\u003C\u002Fa> for the development of a DTx solution for patients with schizophrenia. The software will help patients in adjusting their behaviour by leveraging cognitive and neurobehavioral mechanisms. \u003C\u002Fp>\n\n\n\n\u003Cp>The following month, it \u003Ca href=\"https:\u002F\u002Fpharmaphorum.com\u002Fnews\u002Fboehringer-yale-trial-digital-tech-in-heart-failure\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">partnered with Yale University\u003C\u002Fa> on a new trial involving a digital health technology. The latter, a smart bathroom scale, integrates cardiac monitoring and a companion app to help cardiac patients better manage their condition and improve their prospects. \u003C\u002Fp>\n\n\n\n\u003Cp>And this September, it \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fpharmaphorum.com\u002Fnews\u002Fcoalition-formed-to-represent-patient-interests-in-digital-health\u002F\" target=\"_blank\">sponsored a new coalition\u003C\u002Fa>, the Patient Coalition for AI, Data and Digital Tech in Health. It aims to ensure that patients can access digital health services equitably.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Takeda: pushing for digital health innovation\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Considering Japanese multinational pharmaceutical company Takeda’s recent moves, the big fish seems to incentivise innovative projects that can improve the healthcare ecosystem. \u003C\u002Fp>\n\n\n\n\u003Cp>This March, it \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.shine.cn\u002Fbiz\u002Fcompany\u002F2103226334\u002F\" target=\"_blank\">launched TakedaSpark\u003C\u002Fa>, an incubation platform, in Shanghai. Through TakedaSpark, Takeda aims to boost digital health innovation through new projects and partnerships.\u003Cem> “We hope to use flexible, innovative and high-quality products to provide better treatments for patients,”\u003C\u002Fem> \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.shine.cn\u002Fbiz\u002Fcompany\u002F2103226334\u002F\" target=\"_blank\">said Sean Shan\u003C\u002Fa>, president of Takeda China. \u003Cem>“Digitalisation will be an empowering tool to expedite our overall efficiency, and it’s also crucial for how we connect with various stakeholders and collaborators.”\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cp>In line with such efforts, Takeda also \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Femea\u002Froundup-orcha-calls-developers-create-apps-long-covid-airflow-simulation-technology\" target=\"_blank\">held its Digital Health Innovation Challenge\u003C\u002Fa> earlier this year. Winners of the challenge are able to partner with the pharma company, and also benefit from funding to help commercialise their projects. One of this year’s winners, IDUN Technologies, focuses on sleep disorders. It \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.venturelab.swiss\u002FIDUN-Technologies-wins-the-Takeda-Digital-Health-Innovation-Challenge-to-further-enable-the-Internet-of-Humans\" target=\"_blank\">develops headphones\u003C\u002Fa> to monitor and promote sleep onset through neuromodulation.\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F10\u002F040_sleepelf-768x432.png\" alt=\"SleepOn Go2Sleep review\" class=\"wp-image-22064\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F10\u002F040_sleepelf-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F10\u002F040_sleepelf-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F10\u002F040_sleepelf-512x288.png 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2018\u002F10\u002F040_sleepelf.png 870w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>AstraZeneca: big pharma and big collabs\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Like Pfizer and Johnson & Johnson, Anglo-Swedish drugmaker AstraZeneca is now closely associated with a COVID-19 vaccine. But \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fbig-pharma-part-one\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">like the former companies\u003C\u002Fa>, AstraZeneca is also eyeing digital health opportunities closely. \u003C\u002Fp>\n\n\n\n\u003Cp>To that end, the pharma company has collaborated with several players in the industry lately. Last December, it \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Femea\u002Fastrazeneca-partners-qureai-early-stage-diagnoses-lung-cancer\" target=\"_blank\">partnered with Quire.ai\u003C\u002Fa>, an A.I. solution provider. Through this collaboration, AstraZeneca will focus on applying A.I. solutions in developing markets to detect lung cancer at an early stage, and hence reduce associated mortality rates. \u003C\u002Fp>\n\n\n\n\u003Cp>This April, AstraZeneca \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedcitynews.com\u002F2021\u002F04\u002Fastrazeneca-lands-first-big-partner-for-digital-health-platform\u002F\" target=\"_blank\">announced a collaboration\u003C\u002Fa> with Massachusetts General Hospital. The latter will employ the drugmaker’s digital health platform for heart failure and asthma management in a real-world setting. In the same month, AstraZeneca \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fnvidia-partners-astrazeneca-and-university-florida-ai-powered-drug-discovery\" target=\"_blank\">partnered with\u003C\u002Fa> NVIDIA and the University of Florida for a new drug-discovery project. The latter will use the new MegaMoIBART model that leverages NVIDIA’s A.I. drug discovery platform and a new kind of technology called transformer neural networks. According to Kimberly Powell, VP of healthcare at NVIDIA, \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fnvidia-partners-astrazeneca-and-university-florida-ai-powered-drug-discovery\" target=\"_blank\">transformer neural networks could help\u003C\u002Fa> accelerate research and speed up drug discovery.\u003C\u002Fp>\n\n\n\n\u003Cp>AstraZeneca also announced another partnership in August \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Frenalytix-ai-and-astrazeneca-team-improve-chronic-kidney-disease-outcomes\" target=\"_blank\">with Renalytix AI\u003C\u002Fa>, an A.I.-enabled in vitro diagnostics company. With the latter’s KidneyIntelX platform, the team’s researchers will assign a risk score to chronic kidney disease patients based on their medical records. Physicians can subsequently use this score to determine the progression of the disease and prevent complications. \u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002FAI-doctor-image-768x432.jpg\" alt=\"\" class=\"wp-image-28295\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002FAI-doctor-image-768x432.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002FAI-doctor-image-370x208.jpg 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002FAI-doctor-image-1536x864.jpg 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F05\u002FAI-doctor-image.jpg 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>The pharma giant is also showing some interest in point-of-care devices. In August 2020, it \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fastrazeneca-taps-eko-heart-screening-initiative\" target=\"_blank\">teamed up with Eko\u003C\u002Fa> to use the latter’s digital health tools in clinical trials. Eko is itself known for \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fbridge-tradition-innovation-eko-core-digital-stethoscope-review\u002F\" target=\"_blank\">developing smart digital stethoscopes\u003C\u002Fa>. AstraZeneca announced \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fastrazeneca-taps-alivecor-kidney-focused-collaboration\" target=\"_blank\">another similar partnership with AliveCor\u003C\u002Fa> this February. With the latter’s A.I.-enabled personal ECG devices and algorithms, the team will study new methods, non-invasive methods to manage cardiac and renal issues.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Amgen: small steps\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>For American multinational biopharmaceutical company Amgen, collaborations are also key to its digital health ventures. While it has not been as aggressive in this regard as its competitors, in April, Amgen announced two new digital health collaborations.\u003C\u002Fp>\n\n\n\n\u003Cp>It partnered \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Femea\u002Fliva-healthcare-and-amgen-partner-improve-access-cardiac-rehabilitation\" target=\"_blank\">with Liva Healthcare\u003C\u002Fa>, a digital health coaching company, to develop a tele-rehabilitation solution for cardiac patients. More specifically, it is targeted to help patients gauge and adjust their lifestyle following a heart attack.\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F10\u002F216_tmf-01-768x432.png\" alt=\"Can telepsychology work?\" class=\"wp-image-30867\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F10\u002F216_tmf-01-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F10\u002F216_tmf-01-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F10\u002F216_tmf-01-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F10\u002F216_tmf-01.png 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>Amgen also launched \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.firstwordpharma.com\u002Fnode\u002F1818618\" target=\"_blank\">a new digital health study with Datos Health\u003C\u002Fa> in April. From patient data collected remotely through digital technologies, they will study the feasibility of improving heart failure treatment with better and personalised guidelines. \u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Roche: leveraging its digital health acquisition\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Swiss heavyweight Roche was explicit about its interest in digital health solutions \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fdigital-health-mergers-and-acquisitions-2018\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">relatively early on\u003C\u002Fa>. In 2017, it \u003Ca href=\"https:\u002F\u002Fwww.roche.com\u002Fmedia\u002Freleases\u002Fmed-cor-2017-06-30.htm\" target=\"_blank\" rel=\"noreferrer noopener\">acquired diabetes management start-up mySugr\u003C\u002Fa>, and integrated the app to Roche’s own devices. It maintained its interest in investigating digital health tools in diabetes management in subsequent years and leveraged this key acquisition. \u003C\u002Fp>\n\n\n\n\u003Cp>In April 2021, Roche \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Froches-new-mysugar-feature-lets-users-control-their-insulin-pump-virtually\" target=\"_blank\">integrated mySugr’s Logbook\u003C\u002Fa> with Nordisk’s connected insulin pens, providing patients with more insights into managing their condition. In May, it \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Froches-new-mysugar-feature-lets-users-control-their-insulin-pump-virtually\" target=\"_blank\">added the new Pump Control module\u003C\u002Fa> to the mySugr app. It allows users to deliver a standard bolus remotely with their Accu-Chek Insight insulin pump. The latter device was also \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Froche-inks-deal-diabeloop-integrate-automated-insulin-delivery\" target=\"_blank\">able to integrate with the Diabeloop monitoring system\u003C\u002Fa> following a new partnership by Roche in March. The system’s algorithm continuously monitors and can adjust insulin delivery.\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002FDiabetes-We-Are-Not-Waiting-768x432.jpg\" alt=\"diabetes technology\" class=\"wp-image-24563\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002FDiabetes-We-Are-Not-Waiting-768x432.jpg 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002FDiabetes-We-Are-Not-Waiting-370x208.jpg 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002FDiabetes-We-Are-Not-Waiting-512x288.jpg 512w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2019\u002F08\u002FDiabetes-We-Are-Not-Waiting.jpg 1200w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003Cfigcaption>Source: www.bloomberg.com\u003C\u002Ffigcaption>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>Roche’s recent moves seem invested in healthcare A.I. In September, it inked a deal \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fmedial-earlysign-signs-deal-roche-develop-ai-enabled-cancer-detection-tool\" target=\"_blank\">with Israeli startup Medial EarlySign\u003C\u002Fa> to bring an A.I.-powered early-stage gastric cancer detection tool. Roche also \u003Ca rel=\"noreferrer noopener\" href=\"https:\u002F\u002Fwww.digitalhealthglobal.com\u002Fpatchai-and-roche-signed-a-deal-for-a-digital-health-solution-in-oncology\u002F\" target=\"_blank\">paired with PatchAi\u003C\u002Fa> to develop a cancer patient support software that uses A.I. to engage users in empathic conversations.\u003C\u002Fp>\n\n\n\n\u003Cp>Regarding empathy, Roche Diagnostics India \u003Ca href=\"https:\u002F\u002Fwww.mobihealthnews.com\u002Fnews\u002Fasia\u002Froche-diagnostics-india-develops-wellness-app-healthcare-workers\" target=\"_blank\" rel=\"noreferrer noopener\">launched a dedicated app\u003C\u002Fa> in June to assist in the wellness of healthcare workers amid the COVID-19 pandemic. It provides users with self-help and self-assessment tools, as well as counselling sessions.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>Staying relevant in the digital health era\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>As we come to a close to our series of articles contemplating the digital health endeavours of pharmaceutical giants, we hope the insights collected will prove to be valuable. A common theme among those big pharma companies seems to be the forging of numerous partnerships with industry players. This could indicate a bid to stay relevant in the ever-evolving digital health field. Some companies have also shown promising steps to consider the patient side of things through new studies, patient-centric tools or even advocacy groups.\u003C\u002Fp>\n\n\n\n\u003Chr class=\"wp-block-separator\"\u002F>\n\n\n\n\u003Cp>We will further analyse those general trends in a roundup article. But we hope that this series has given you some insights into where the digital health field might be heading and what aspects of this field that some influential companies are eyeing.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cem>Written by Dr. Bertalan Meskó & Dr. Pranavsingh Dhunnoo\u003C\u002Fem>\u003C\u002Fp>\n\n\n\n\u003Cdiv style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\">\u003C\u002Fdiv>\n\n\n\n\u003Ctable style=\"width: 100%; border-collapse: collapse; background-color: #eee; border-top: 4px solid #444;\" cellpadding=\"10px\">\n\u003Ctbody>\n\u003Ctr>\n\u003Ctd style=\"width: 100%;\">\n\u003Cp>\u003Cstrong>At The Medical Futurist, we are building a community for making a bold vision about the future of healthcare reality today.\u003C\u002Fstrong>\u003C\u002Fp>\n\u003Ciframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\u002F\u002Fwww.youtube.com\u002Fembed\u002FFIbMejImnxs\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\">\u003C\u002Fiframe>\n\u003Cp>If you’d like to support this mission, we invite you to \u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">join The Medical Futurist Patreon Community\u003C\u002Fa>. A community of empowered patients, future-oriented healthcare professionals, concerned health policymakers, sensible health tech developers, and enthusiastic medical students. If there were ever a time to join us, it is now. Every contribution, however big or small, powers our research and sustains our future.\u003C\u002Fp>\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">\u003Cstrong style=\"background-color: #e71d3299; color: #000;\">Click here to support The Medical Futurist from as little as $3\u003C\u002Fstrong>\u003C\u002Fa> – it only takes a minute. Thank you.\u003C\u002Fp>\n\u003C\u002Ftd>\n\u003C\u002Ftr>\n\u003C\u002Ftbody>\n\u003C\u002Ftable>\n\u003Cp> \u003C\u002Fp>\n",false,{"rendered":22,"protected":20},"\u003Cp>With their extending reaches, resources and influence, pharmaceutical heavyweights have the potential to shape the digital health landscape to line up with their interests. And […]\u003C\u002Fp>\n",16,36797,"closed",true,"","standard",{"_acf_changed":20,"footnotes":27},[31,32,33,34],7079,504,798,490,[36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55],7459,7439,631,7441,7443,819,7445,5399,7447,5403,7449,7451,6465,356,7453,402,7455,7339,7457,7437,[57,58,59],947,950,951,[],[62,63,64,65,66,67,68,69,70],1631,1681,1883,2163,5521,1571,1609,1611,1617,[72,14,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102,103,104],"post-36697","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tmf","category-artificial-intelligence","category-digital-health-research","category-future-of-pharma","tag-patchai","tag-boehringer-ingelheim","tag-patient-empowerment","tag-amgen","tag-digitisation","tag-pharmaceutics","tag-quire-ai","tag-roche","tag-renalytix","tag-mysugr","tag-eko","tag-liva-healthcare","tag-astra-zeneca","tag-pharma-2","tag-datos-health","tag-sleep","tag-pump-control","tag-dtx","tag-diabeloop","tag-takeda","project_category-company","project_category-medical-professionals","project_category-patients",{"id":24,"alt_text":27,"caption":27,"description":106,"media_type":107,"media_details":108,"post":5,"source_url":136},"Big Pharma part 3","image",{"width":109,"height":110,"file":111,"sizes":112,"image_meta":134},1920,1080,"2021\u002F11\u002Ftmf_article_301-01.png",{"medium":113,"large":119,"thumbnail":124,"medium_large":128,"1536x1536":129},{"file":114,"width":115,"height":116,"mime-type":117,"source_url":118},"tmf_article_301-01-370x208.png","370","208","image\u002Fpng","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F11\u002Ftmf_article_301-01-370x208.png",{"file":120,"width":121,"height":122,"mime-type":117,"source_url":123},"tmf_article_301-01-768x432.png","768","432","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F11\u002Ftmf_article_301-01-768x432.png",{"file":125,"width":126,"height":126,"mime-type":117,"source_url":127},"tmf_article_301-01-150x150.png","150","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F11\u002Ftmf_article_301-01-150x150.png",{"file":120,"width":121,"height":122,"mime-type":117,"source_url":123},{"file":130,"width":131,"height":132,"mime-type":117,"source_url":133},"tmf_article_301-01-1536x864.png","1536","864","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F11\u002Ftmf_article_301-01-1536x864.png",{"aperture":135,"credit":27,"camera":27,"caption":27,"created_timestamp":135,"copyright":27,"focal_length":135,"iso":135,"shutter_speed":135,"title":27,"orientation":135},"0","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F11\u002Ftmf_article_301-01.png",{"cta_type":138,"cta_color":27,"subtitle":27,"related_books":139,"related_posts_footer":142,"related_posts":20},"subscribe",[140,141],24764,24763,[143,144,145],36507,36643,35721,{"yoast_wpseo_title":147,"yoast_wpseo_metadesc":148,"yoast_wpseo_canonical":15},"Digital Health Interests Of Pharma Giants Boehringer Ingelheim, Takeda, Astrazeneca, Amgen And Roche - The Medical Futurist","Pharmaceutical giants have the potential to shape the digital health landscape. In this series we investigated how big pharma prepares for the next level in medicine.",{"self":150,"collection":156,"about":159,"author":162,"replies":165,"version-history":168,"predecessor-version":172,"wp:featuredmedia":176,"wp:attachment":179,"wp:term":182,"curies":198},[151],{"href":152,"targetHints":153},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F36697",{"allow":154},[155],"GET",[157],{"href":158},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts",[160],{"href":161},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftypes\u002Fpost",[163],{"embeddable":26,"href":164},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fusers\u002F16",[166],{"embeddable":26,"href":167},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=36697",[169],{"count":170,"href":171},13,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F36697\u002Frevisions",[173],{"id":174,"href":175},36795,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F36697\u002Frevisions\u002F36795",[177],{"embeddable":26,"href":178},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F36797",[180],{"href":181},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=36697",[183,186,189,192,195],{"taxonomy":184,"embeddable":26,"href":185},"category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=36697",{"taxonomy":187,"embeddable":26,"href":188},"post_tag","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=36697",{"taxonomy":190,"embeddable":26,"href":191},"project_category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fproject_category?post=36697",{"taxonomy":193,"embeddable":26,"href":194},"contact_email_category","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcontact_email_category?post=36697",{"taxonomy":196,"embeddable":26,"href":197},"yst_prominent_words","https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=36697",[199],{"name":200,"href":201,"templated":26},"wp","https:\u002F\u002Fapi.w.org\u002F{rel}",[203],{"id":145,"date":204,"date_gmt":205,"guid":206,"modified":208,"modified_gmt":209,"slug":210,"status":13,"type":14,"link":211,"title":212,"content":214,"excerpt":216,"author":218,"featured_media":219,"comment_status":25,"ping_status":25,"sticky":26,"template":27,"format":28,"meta":220,"categories":221,"tags":230,"project_category":246,"contact_email_category":249,"yst_prominent_words":250,"class_list":262,"better_featured_image":289,"acf":309,"yoast_meta":317,"_links":320},"2021-08-24T10:00:00","2021-08-24T08:00:00",{"rendered":207},"https:\u002F\u002Fmedicalfuturist.com\u002F?post_id=35721&_wpnonce=7ec1f67adf&status=auto-draft&type=post","2021-09-16T12:59:35","2021-09-16T10:59:35","tech-giants-in-healthcare-2021-summary","https:\u002F\u002Fmedicalfuturist.com\u002Ftech-giants-in-healthcare-2021-summary",{"rendered":213},"Big Tech In Medicine: How Amazon, Apple, Microsoft, Google, IBM & NVIDIA Disrupt Healthcare",{"rendered":215,"protected":20},"\n\u003Cp>\u003Cstrong>We’ve spent a good part of our summer writing about Big Tech and how these companies, \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Famazons-march-into-healthcare-a-2021-update\">Amazon\u003C\u002Fa>, \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fgoogles-masterplan-for-healthcare\">Google\u002FAlphabet\u003C\u002Fa>, \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fmicrosoft-in-healthcare-2021\">Microsoft\u003C\u002Fa>, \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fapple-in-healthcare-2021\">Apple\u003C\u002Fa>, \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fibm-in-healthcare-2021\">IBM\u003C\u002Fa> and \u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fnvidia-in-healthcare-2021\">NVIDIA\u003C\u002Fa> have approached medicine and its trillion-dollar market possibilities. These six companies have the most projects in healthcare, and their presence is not negligible at all: they all have the power and the incentive to transform and help digitise this market.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-image\">\u003Cfigure class=\"aligncenter size-large\">\u003Ca class=\"img\" href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fbig-tech-in-healthcare-heatmap\" target=\"_blank\" rel=\"noopener\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"564\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Fbigtech_infographic-1-1-768x564.png\" alt=\"\" class=\"wp-image-36219\"\u002F\u003C\u002Fa srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Fbigtech_infographic-1-1-768x564.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Fbigtech_infographic-1-1-1536x1129.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F09\u002Fbigtech_infographic-1-1.png 1469w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Fa>\u003Cfigcaption>Big Tech In Healthcare – heatmap\u003C\u002Ffigcaption>\u003C\u002Ffigure>\u003C\u002Fdiv>\n\n\n\n\u003Cp>Moreover, all of these companies have something peculiar and very unique to give. Amazon’s distribution network can change the way we think of pharmacies in the future. Microsoft can bring steadiness, reason and predictability. Apple’s design and seamless approach make us see systems as flawless organisms. Google’s in-depth knowledge of A.I. and its practical use in cure. IBM bringing its power and history onto the field of machine learning and quantum computing. And last but not least, a relative newcomer, NVIDIA knowing how to manufacture systems and practical implementations.\u003Cbr>\u003Cbr>In this closing part of the series, we give you a final summary and analysis on where we think Tech Giants are heading – and if you want to read more about these companies and what they have already done and achieved in healthcare, we recommend you to get your copy of our e-book, \u003Ca href=\"https:\u002F\u002Fleanpub.com\u002Ftech-giants-in-healthcare\">Tech Giants In Healthcare\u003C\u002Fa>!\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\">\u003Cdiv class=\"wp-block-embed__wrapper\">\n\u003Ciframe loading=\"lazy\" title=\"Tech Giants in Healthcare - Updated with COVID-19! The Medical Futurist\" width=\"640\" height=\"360\" src=\"https:\u002F\u002Fwww.youtube.com\u002Fembed\u002FXX6-kzy2XK4?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen>\u003C\u002Fiframe>\n\u003C\u002Fdiv>\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Famazons-march-into-healthcare-a-2021-update\">\u003Cstrong>Amazon’s Dive Into Healthcare\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fh2>\n\n\n\n\u003Cp>With its thorough knowledge of online sales and distribution, it was inevitable that one of the milestones of this tech giant’s steps in healthcare will include the disruption of pharma distribution chains. As we wrote in our related article, in 2017, when Amazon received drug distribution licenses in over 10 U.S. states, the news sent traditional players in the pharmaceutical market into a frenzy. Amazon’s pharm plans further expanded when it bought startup online pharmacy PillPack for nearly $1 billion in 2018, ultimately selling over-the-counter medications, prescription drugs, and its own line of OTC drugs. And, of course, this isn’t all.\u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">\u003Cstrong>\u003Cem>What Amazon is betting on\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\u003Cli>Providing telehealth services for its employees and later to other customers primarily in the U.S.\u003C\u002Fli>\u003Cli>Using its supply chain to quickly deliver medications\u003C\u002Fli>\u003Cli>Using Alexa for chatbot-based medical services\u003C\u002Fli>\u003C\u002Ful>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">\u003Cstrong>\u003Cem>What I expect\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cp>\u003Cstrong>Amazon will make further use of its vast knowledge of online shopping trends and behaviour and will keep on providing what people need, from medicine to wearables. It might encounter some difficulties in areas they know less; but as it is already active in the most profitable segment of medicine (pharma manufacturing and sales), it can maintain its profitability. So no Amazon hospital, but yes to fields that can be built with data from e-commerce.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\">\u003Cdiv class=\"wp-block-embed__wrapper\">\n\u003Ciframe loading=\"lazy\" title=\"How Amazon Could Revolutionise Healthcare - A Future Bit From The Medical Futurist\" width=\"640\" height=\"360\" src=\"https:\u002F\u002Fwww.youtube.com\u002Fembed\u002FppB7OOzcoTc?start=1&feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen>\u003C\u002Fiframe>\n\u003C\u002Fdiv>\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fapple-in-healthcare-2021\u002F\">\u003Cstrong>Apple’s Venture in Health\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fh2>\n\n\n\n\u003Cp>Producing a device every 6th people has in their pocket worldwide, it seems clear how Apple can reach the field to play on. Not to mention another health tool: Apple \u003Ca href=\"https:\u002F\u002Fwww.statista.com\u002Fstatistics\u002F524830\u002Fglobal-smartwatch-vendors-market-share\u002F\">holds the largest share\u003C\u002Fa> of the global smartwatch shipment market. In the first quarter of 2020, that accounted for a substantial 47.9% share of the market. The company has been heavily leveraging the popularity of its smartwatch for its healthcare plans.\u003C\u002Fp>\n\n\n\n\u003Cp>Through Apple Watch, the company has built an excellent pathway to electronic health records, too. Apple’s \u003Ca href=\"https:\u002F\u002Fsupport.apple.com\u002Fen-us\u002FHT203037\">Health app\u003C\u002Fa> aims to bridge patients and doctors, and all the data in-between. Users can share their health data collected by the Health app directly to EMRs, like Cerner, which is already supporting this feature. Seamlessly sharing patient healthcare data from an Apple device to an EMR and this being viewable by a doctor or caregiver represent a major step in facilitating digital health approaches.\u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">\u003Cstrong>\u003Cem>What Apple is betting on\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\u003Cli>Using the Apple Watch for consumer health and research\u003C\u002Fli>\u003Cli>Connecting the Apple Health app to selected third-party services\u003C\u002Fli>\u003C\u002Ful>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">\u003Cstrong>\u003Cem>What I expect\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cp>\u003Cstrong>Apple will keep on working on expanding the health features of its devices, Apple Watch and iPhones included. Even more, I think some of the new features introduced in the next iPhones will be more health- than tech-related! Apple-owned clinics? The news was out but the company retreated, keeping a clear portfolio.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F07\u002Ftmf_article_279-01-768x432.png\" alt=\"\" class=\"wp-image-35099\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F07\u002Ftmf_article_279-01-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F07\u002Ftmf_article_279-01-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F07\u002Ftmf_article_279-01-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F07\u002Ftmf_article_279-01.png 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fgoogles-masterplan-for-healthcare\u002F\">\u003Cstrong>Google’s Masterplan for Healthcare\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fh2>\n\n\n\n\u003Cp>Of all these tech giants, Google is the one that knows what \u003Cem>exactly\u003C\u002Fem> people want. Even more: \u003Ca href=\"https:\u002F\u002Fwww.cnbc.com\u002F2019\u002F11\u002F15\u002Fgoogle-tweaks-its-algorithm-to-change-search-results-wsj.html\">some say\u003C\u002Fa> it can even direct that will. And people sure want health: 7% of all Google searches (an astounding 70,000 per minute) is health-related around the world. The search giant has repeatedly successfully transferred its in-depth knowledge of algorithms in the field of medicine, particularly since it acquired DeepMind.\u003C\u002Fp>\n\n\n\n\u003Cp>After a successful pilot in supporting cancer research, Google put its A.I. and its cloud computing expertise to use in partnerships. May 2021 HCA Healthcare and Alphabet’s Google Cloud announced a collaboration to develop algorithms to mine insights in patient records from the provider to improve efficiency and patient outcomes; and also this year the giant introduced its dermatology app supporting skin cancer monitoring and diagnosis.\u003C\u002Fp>\n\n\n\n\u003Cp>Google had some missteps along the way, too, from Google Glass to launching-relaunching, now shutting down again its Google Health branch. But don’t give up on Google in healthcare: if the company want in, it will be in. \u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">\u003Cstrong>\u003Cem>What Google\u002FAlphabet is betting on\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\u003Cli>Scrapping Google Health and giving more space to small-scale projects with more autonomy\u003C\u002Fli>\u003Cli>Improving A.I. for medical and research purposes with DeepMind\u003C\u002Fli>\u003Cli>Investing into a ton of startups and directions through Verily and GV\u003C\u002Fli>\u003C\u002Ful>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">\u003Cstrong>\u003Cem>What I expect\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cp>\u003Cstrong>Through its investment funds GV and Gradient Ventures, Google is successfully keeping its fingers on the pulse of healthcare-related startups and ideas. It keeps being a driving force behind health- and A.I.-related investments. Google sure learned how \u003Ca href=\"https:\u002F\u002Fwww.youtube.com\u002Fwatch?v=QfQ2r0zvyoA\">information is everything\u003C\u002Fa>, and already built an empire on top. Also, it’s easy to expect to see more A.I.-related medical breakthroughs from them.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002F0823_google_infographic-01-768x432.png\" alt=\"\" class=\"wp-image-35717\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002F0823_google_infographic-01-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002F0823_google_infographic-01-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002F0823_google_infographic-01-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002F0823_google_infographic-01-2048x1152.png 2048w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002F0823_google_infographic-01.png 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003Cfigcaption>Google In Healthcare – An Infographic (2021)\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fmicrosoft-in-healthcare-2021\u002F\">\u003Cstrong>Microsoft Makes a 16-billion Dollar Bet On Healthcare\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fh2>\n\n\n\n\u003Cp>Microsoft has always focused on the enterprise side of anything it entered into. Throughout 2020, the company strengthened its healthcare-related partnerships with organisations and research institutes. By delivering its computing know-how and the fact that most medical professionals are familiar with the way Microsoft’s computers are built and operate, the tech giant only needs to keep being good at what it already knows.\u003C\u002Fp>\n\n\n\n\u003Cp>Last October, Microsoft launched Cloud for Healthcare, a new, healthcare-centric cloud. It integrates the company’s existing services like Microsoft Teams, Azure IoT and its Healthcare Bot. These tools aim to assist with collaboration among staff and carry out telemedicine consultations. In April 2021 Microsoft acquired A.I.-powered speech-technology company, Nuance. The company’s software can listen and transcribe doctor-patient conversations into organized medical notes.\u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">\u003Cstrong>\u003Cem>What Microsoft is betting on\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\u003Cli>Cloud computing\u003C\u002Fli>\u003Cli>Health IT services (doesn’t sound sexy, but it makes healthcare work)\u003C\u002Fli>\u003C\u002Ful>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">\u003Cstrong>\u003Cem>What I expect\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cp>\u003Cstrong>For me Microsoft is just like a liked uncle in the family: you can always count on him showing up at family gatherings, bringing flowers and a set of old jokes. Microsoft might not be a forerunner in healthcare, but what it promises, the company will surely deliver. So I expect it to be a poised partner for hospitals and health institutions\u002Funiversities, providing its massive knowledge and infrastructure to support research and development. \u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002Ftmf_article_283-01-768x432.png\" alt=\"\" class=\"wp-image-35453\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002Ftmf_article_283-01-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002Ftmf_article_283-01-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002Ftmf_article_283-01-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002Ftmf_article_283-01.png 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003Cfigcaption>Microsoft In Healthcare, 2021\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">\u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fibm-in-healthcare-2021\u002F\">\u003Cstrong>IBM’s Moonshot Ambition In Healthcare\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fh3>\n\n\n\n\u003Cp>For over a century, tech company IBM was known for its innovation and client focus. But in recent years, its glory in innovation has faded. The company tried to build a stronghold in artificial intelligence with Watson, but the program is currently scrapped, as “\u003Cem>physicians were hesitant to adopt artificial intelligence.\u003C\u002Fem>” So after having spent years developing the branch and having invested considerable resources into it, IBM abandoning these efforts altogether comes as a surprise.\u003C\u002Fp>\n\n\n\n\u003Cp>In quantum computing, IBM took the lead but is in a tight race with other tech giants like Google. IBM is also trying to stay on board with being at the forefront of the use of blockchain in a medical setting, co-operating for example with Moderna, and having enterprise-level customers like the State of New York for a blockchain-secured health certificate app.\u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">\u003Cstrong>\u003Cem>What IBM is betting on\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\u003Cli>Trying to rebrand IBM Watson as a healthcare A.I.\u003C\u002Fli>\u003Cli>Seeing the future in quantum computing\u003C\u002Fli>\u003C\u002Ful>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">\u003Cstrong>\u003Cem>What I expect\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cp>\u003Cstrong>IBM seems to be keeping a straightforward path with the eyes on the prize. The company does not attempt to enter fields it lacks the knowledge on, which I consider a good (and financially stable) thing. Once again, I don’t expect to have IBM hospitals or clinics, but healthcare institutions, using all IBM has to offer in federated learning, blockchain and quantum computing. Which is, quite a lot.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002Ftmf_article_284-01-768x432.png\" alt=\"\" class=\"wp-image-35515\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002Ftmf_article_284-01-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002Ftmf_article_284-01-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002Ftmf_article_284-01-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002Ftmf_article_284-01.png 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003Cfigcaption>IBM In Healthcare, 2021\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Ca href=\"https:\u002F\u002Fmedicalfuturist.com\u002Fnvidia-in-healthcare-2021\u002F\" target=\"_blank\" rel=\"noreferrer noopener\">\u003Cstrong>NVIDIA, From Gaming To Medicine\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fh2>\n\n\n\n\u003Cp>Who would’ve thought NVIDIA has been active in healthcare for over a decade – the company helped bring innovative diagnostic imaging, robotic surgery and patient monitoring devices to the market. The processor unit manufacturer launched its A.I. platform, Clara in 2018, designed to augment medical imaging and genomics. It followed up a year later with a toolkit for radiologists, Clara A.I., to help with the classification of images. In 2019, the tech giant also started to explore federated learning in healthcare, the privacy-focused A.I. training method.\u003C\u002Fp>\n\n\n\n\u003Cp>NVIDIA, too, thought speech recognition technology would grow in importance in the future. Their software can help transcribe and better organise information from telemedicine visits. But probably their most important added value in healthcare will be the Cambridge-1 supercomputer the company is building in the UK. The UK’s most powerful supercomputer will aid in A.I. research in healthcare.\u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">\u003Cstrong>\u003Cem>What NVIDIA is betting on\u003C\u002Fem>\u003C\u002Fstrong> \u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\u003Cli>Using its supercomputers and chips to improve drug design, genomics research and chatbots, among others\u003C\u002Fli>\u003C\u002Ful>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">\u003Cstrong>\u003Cem>What I expect\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cp>\u003Cstrong>NVIDIA seems incredibly focused in its approach towards healthcare. The company uses its strengths in data, machine learning and hardware manufacturing, and builds these all into its vision for healthcare, which is efficient, fast and entirely high-tech. Honestly, I can share their enthusiasm. We can expect NVIDIA to be a leader in the use of artificial intelligence in healthcare – maybe not the data-driven, but more the creative part of the field\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"432\" src=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F08\u002F190_tmf-01-768x432.png\" alt=\"Gamification in healthcare\" class=\"wp-image-29397\" srcset=\"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F08\u002F190_tmf-01-768x432.png 768w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F08\u002F190_tmf-01-370x208.png 370w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F08\u002F190_tmf-01-1536x864.png 1536w, https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2020\u002F08\u002F190_tmf-01.png 1920w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \u002F>\u003Cfigcaption>Gaming In Healthcare – Death Stranding’s delivery guy\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Chr class=\"wp-block-separator\"\u002F>\n\n\n\n\u003Cp>\u003Cstrong>With this, we have finished this round of talking about Big Tech in medicine. Their weight, level of involvement, size of investment and even their approach vary, but they all make waves in healthcare. Given their background, they all focus on the technological side of medicine, and here’s the only bit I’m missing from their side: patient centricity. \u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>But just as healthcare is complex and requires as much technology as empathy and care, I’m sure patient focus and even involvement will inevitably come.\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch4 class=\"wp-block-heading\">\u003Cstrong>For now, I am only sure that we’ll hear more about these companies in healthcare. As news of their endeavours is coming out almost every day, their steps will not go unnoticed. I’m also looking forward to having my forecasts challenged!\u003C\u002Fstrong>\u003C\u002Fh4>\n\n\n\n\u003Cdiv style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\">\u003C\u002Fdiv>\n\n\n\n\u003Ctable style=\"width: 100%; border-collapse: collapse; background-color: #eee; border-top: 4px solid #444;\" cellpadding=\"10px\">\n\u003Ctbody>\n\u003Ctr>\n\u003Ctd style=\"width: 100%;\">\n\u003Cp>\u003Cstrong>At The Medical Futurist, we are building a community for making a bold vision about the future of healthcare reality today.\u003C\u002Fstrong>\u003C\u002Fp>\n\u003Ciframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\u002F\u002Fwww.youtube.com\u002Fembed\u002FFIbMejImnxs\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\">\u003C\u002Fiframe>\n\u003Cp>If you’d like to support this mission, we invite you to \u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">join The Medical Futurist Patreon Community\u003C\u002Fa>. A community of empowered patients, future-oriented healthcare professionals, concerned health policymakers, sensible health tech developers, and enthusiastic medical students. If there were ever a time to join us, it is now. Every contribution, however big or small, powers our research and sustains our future.\u003C\u002Fp>\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fwww.patreon.com\u002Fthemedicalfuturist\">\u003Cstrong style=\"background-color: #e71d3299; color: #000;\">Click here to support The Medical Futurist from as little as $3\u003C\u002Fstrong>\u003C\u002Fa> – it only takes a minute. Thank you.\u003C\u002Fp>\n\u003C\u002Ftd>\n\u003C\u002Ftr>\n\u003C\u002Ftbody>\n\u003C\u002Ftable>\n\u003Cp> \u003C\u002Fp>\n",{"rendered":217,"protected":20},"\u003Cp>We’ve spent a good part of our summer writing about Big Tech and how these companies, Amazon, Google\u002FAlphabet, Microsoft, Apple, IBM and NVIDIA have approached […]\u003C\u002Fp>\n",6,35723,{"_acf_changed":20,"footnotes":27},[31,222,32,33,223,34,224,225,226,227,228,229],6261,521,488,802,496,497,799,494,[231,232,233,234,235,236,237,238,239,240,241,242,243,244,245],7279,1056,7305,569,7335,142,7337,266,5039,281,6203,862,6733,6763,6931,[57,58,247,248],952,953,[],[251,252,67,253,254,255,256,257,258,64,259,260,261],2739,2935,3305,1595,4363,1683,1715,1723,2347,2351,2355,[263,14,73,74,75,76,77,78,264,79,80,265,81,266,267,268,269,270,271,272,273,274,275,276,277,278,279,280,281,282,283,284,285,286,102,103,287,288],"post-35721","category-forecast","category-future-medicine","category-genomics","category-health-insurance","category-health-sensors-trackers","category-portable-diagnostics","category-security-privacy","category-telemedicine","tag-alphabet","tag-watson","tag-nuance","tag-microsoft","tag-google-cloud","tag-apple","tag-azure","tag-google-2","tag-tech-giants","tag-ibm","tag-big-tech","tag-nvidia","tag-cloud-computing","tag-federated-learning","tag-nvidia-clara","project_category-policy-makers","project_category-researchers",{"id":219,"alt_text":27,"caption":27,"description":290,"media_type":107,"media_details":291,"post":145,"source_url":308},"Tech giants in healthcare - 2021",{"width":109,"height":110,"file":292,"sizes":293,"image_meta":307},"2021\u002F08\u002Ftmf_article_286-01.png",{"medium":294,"large":297,"thumbnail":300,"medium_large":303,"1536x1536":304},{"file":295,"width":115,"height":116,"mime-type":117,"source_url":296},"tmf_article_286-01-370x208.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002Ftmf_article_286-01-370x208.png",{"file":298,"width":121,"height":122,"mime-type":117,"source_url":299},"tmf_article_286-01-768x432.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002Ftmf_article_286-01-768x432.png",{"file":301,"width":126,"height":126,"mime-type":117,"source_url":302},"tmf_article_286-01-150x150.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002Ftmf_article_286-01-150x150.png",{"file":298,"width":121,"height":122,"mime-type":117,"source_url":299},{"file":305,"width":131,"height":132,"mime-type":117,"source_url":306},"tmf_article_286-01-1536x864.png","https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002Ftmf_article_286-01-1536x864.png",{"aperture":135,"credit":27,"camera":27,"caption":27,"created_timestamp":135,"copyright":27,"focal_length":135,"iso":135,"shutter_speed":135,"title":27,"orientation":135},"https:\u002F\u002Fcdn.medicalfuturist.com\u002Fwp-content\u002Fuploads\u002F2021\u002F08\u002Ftmf_article_286-01.png",{"subtitle":27,"cta_type":138,"cta_color":27,"related_books":310,"related_posts_footer":313,"related_posts":20},[311,312],24761,31417,[314,315,316],35019,14157,20749,{"yoast_wpseo_title":318,"yoast_wpseo_metadesc":319,"yoast_wpseo_canonical":211},"Big Tech In Medicine: How Amazon, Apple, Microsoft, Google, IBM & NVIDIA Disrupt Healthcare - The Medical Futurist","Tech giants in healthcare: we looked at how these companies, Amazon, Google\u002FAlphabet, Microsoft, Apple, IBM and NVIDIA have approached medicine.",{"self":321,"collection":326,"about":328,"author":330,"replies":333,"version-history":336,"predecessor-version":340,"wp:featuredmedia":344,"wp:attachment":347,"wp:term":350,"curies":361},[322],{"href":323,"targetHints":324},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F35721",{"allow":325},[155],[327],{"href":158},[329],{"href":161},[331],{"embeddable":26,"href":332},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fusers\u002F6",[334],{"embeddable":26,"href":335},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcomments?post=35721",[337],{"count":338,"href":339},24,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F35721\u002Frevisions",[341],{"id":342,"href":343},36235,"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fposts\u002F35721\u002Frevisions\u002F36235",[345],{"embeddable":26,"href":346},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia\u002F35723",[348],{"href":349},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fmedia?parent=35721",[351,353,355,357,359],{"taxonomy":184,"embeddable":26,"href":352},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcategories?post=35721",{"taxonomy":187,"embeddable":26,"href":354},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Ftags?post=35721",{"taxonomy":190,"embeddable":26,"href":356},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fproject_category?post=35721",{"taxonomy":193,"embeddable":26,"href":358},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fcontact_email_category?post=35721",{"taxonomy":196,"embeddable":26,"href":360},"https:\u002F\u002Fapi.medicalfuturist.com\u002Fwp-json\u002Fwp\u002Fv2\u002Fyst_prominent_words?post=35721",[362],{"name":200,"href":201,"templated":26},[],1788949187713]